J. Ravetch

Immunology · 2000–2014

A researcher in the Science corpus: 19 papers; trusts 2 researchers and is trusted by 22 researchers here, as inferred from the citation graph.

Subfields

Whom J. Ravetch trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. F. Nimmerjahn

Who trusts J. Ravetch overall

  1. F. Nimmerjahn
  2. T. Takai
  3. L. Lanier
  4. T. Kawakami
  5. S. Gordon
  6. Mitchell R. Smith
  7. Taku Okazaki
  8. F. Sallusto
  9. A. Klos
  10. R. Jefferis

Papers from J. Ravetch's perspective

Ordered by how strongly the researchers J. Ravetch trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. (Journal of Clinical Oncology)
  2. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation (Science)
  3. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. (Annual Review of Immunology)
  4. The biology of IGE and the basis of allergic disease. (Annual Review of Immunology)
  5. Competence and competition: the challenge of becoming a long-lived plasma cell (Nature reviews. Immunology)
  6. The impact of glycosylation on the biological function and structure of human immunoglobulins. (Annual Review of Immunology)
  7. Engineered antibody Fc variants with enhanced effector function.
  8. Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo 1 (Journal of Immunology)
  9. Fcgamma receptors as regulators of immune responses. (Nature reviews. Immunology)
  10. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. (Immunity)

Their papers